+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Automated & Closed Cell Therapy Processing Systems Market - Global Forecast 2026-2032- Product Image
Automated & Closed Cell Therapy Processing Systems Market - Global Forecast 2026-2032- Product Image
New

Automated & Closed Cell Therapy Processing Systems Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 182 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6081813
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Automated and closed cell therapy processing systems are driving significant transformations in manufacturing efficiency, risk mitigation, and scalability for cell-based therapies. This concise overview delivers actionable market intelligence tailored to senior decision-makers evaluating technology adoption, procurement, and strategic partnerships.

Market Snapshot: Automated & Closed Cell Therapy Processing Systems Market

The Automated & Closed Cell Therapy Processing Systems Market expanded from USD 1.24 billion in 2025 to USD 1.43 billion in 2026 and is predicted to reach USD 3.63 billion by 2032, reflecting a CAGR of 16.49%. Robust growth is underpinned by strong clinical uptake, regulatory momentum, and increasing demand for scalable, GMP-compliant production platforms supporting both autologous and allogeneic therapies.

Scope & Segmentation of the Automated & Closed Cell Therapy Processing Systems Market

  • Product Types: Automated Systems, emphasizing consistency and throughput in process control; Closed Systems, focused on simplifying aseptic workflows and contamination risk reduction.
  • Applications: Platforms tailored for hematopoietic stem cell, mesenchymal stem cell, natural killer cell, CAR T, and patient-specific autologous therapies.
  • Technology Modalities: Core approaches include centrifugation (density gradient, fixed angle, swing bucket), filtration (microfiltration, ultrafiltration), and magnetic separation (immunomagnetic bead, paramagnetic systems).
  • End Users: Contract research organizations, hospitals and clinics, pharmaceutical and biotech companies, and research institutes with distinct process and scale requirements.
  • Process Types: Cell counting and analysis, preparation, separation, storage, and washing, reflecting the breadth of manufacturing and translational workflows.
  • Regions: Americas, Europe, Middle East & Africa, and Asia-Pacific, each presenting unique regulatory and commercial dynamics.

Key Takeaways for Senior Leaders

  • Automated and closed processing solutions now command priority in cell therapy manufacturing strategies, as operational control and regulatory compliance demands intensify.
  • The integration of single-use consumables, digital analytics, and closed-system automation delivers higher assurance of product quality and supports seamless process transfer across sites.
  • Flexible manufacturing architectures enable the same platforms to transition between autologous and allogeneic therapies, reducing the need for extensive revalidation and enhancing return on investment.
  • Decentralized production models—such as hospital-based manufacturing—are accelerating adoption of compact, user-friendly processing systems equipped with remote-support functionalities.
  • Sustainability and supply chain resilience are increasingly central to purchasing decisions, with firms evaluating options for local sourcing, consumables management, and risk mitigation.
  • Strategic alliances—combining equipment, consumables, and digital platforms—help reduce onboarding friction and expedite clinical readiness for diverse organizations.

Tariff Impact on Procurement and Regional Sourcing

Anticipated 2025 tariff developments affecting biomedical instruments introduce complexities that shift supplier selection priorities and total cost of ownership evaluations. Manufacturers are intensifying efforts toward supplier diversification and local sourcing to mitigate tariff exposure and logistics volatility. These pressures especially affect capital-intensive assets and high-consumption consumables, influencing decisions around regional manufacturing footprints. Vendors are adapting by offering bundled solutions and consignment inventory models to smooth cost impacts. Ensuring new supply partners meet GMP and regulatory standards remains vital to avoid downstream validation or compliance issues.

Research Methodology & Data Sources

This analysis integrates primary interviews with process engineers, clinical leaders, and procurement specialists alongside structured vendor assessments. Secondary research encompasses regulatory review, standards analysis, and scenario-driven studies to validate strategic insights. Quality control includes expert peer review and triangulation across datasets.

Why This Report Matters

  • Supports investment and procurement leaders in selecting platforms and suppliers equipped for evolving process and regulatory standards in cell therapy manufacturing.
  • Enables strategic planning to integrate modular, interoperable technology solutions that reduce onboarding friction and enhance operational continuity.

Conclusion

Adopting modular, integrated, and resilient cell therapy processing systems is critical to bridging clinical intent and manufacturing reality. Investing in digital capability and flexible supply arrangements empowers organizations to remain competitive and compliant in a fast-evolving ecosystem.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Automated & Closed Cell Therapy Processing Systems Market, by Product Type
8.1. Automated Systems
8.2. Closed Systems
9. Automated & Closed Cell Therapy Processing Systems Market, by Technology
9.1. Centrifugation
9.1.1. Density Gradient Centrifugation
9.1.2. Fixed Angle Centrifugation
9.1.3. Swing Bucket Centrifugation
9.2. Filtration
9.2.1. Microfiltration
9.2.2. Ultrafiltration
9.3. Magnetic Separation
9.3.1. Immunomagnetic Bead Separation
9.3.2. Paramagnetic Separation
10. Automated & Closed Cell Therapy Processing Systems Market, by Process Type
10.1. Cell Counting & Analysis
10.1.1. Automated Counting
10.1.2. Manual Counting
10.2. Cell Separation
10.2.1. Centrifugation Separation
10.2.2. Filtration Separation
10.2.3. Magnetic Separation
10.3. Cell Preparation
10.4. Cell Storage
10.5. Cell Washing
11. Automated & Closed Cell Therapy Processing Systems Market, by Application
11.1. Allogeneic
11.1.1. Hematopoietic Stem Cell Therapy
11.1.2. Natural Killer Cell Therapy
11.2. Autologous
11.2.1. Car T Cell Therapy
11.2.2. Mesenchymal Stem Cell Therapy
12. Automated & Closed Cell Therapy Processing Systems Market, by End User
12.1. Contract Research Organizations
12.2. Hospitals & Clinics
12.3. Pharmaceutical & Biotech Companies
12.4. Research Institutes
13. Automated & Closed Cell Therapy Processing Systems Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Automated & Closed Cell Therapy Processing Systems Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Automated & Closed Cell Therapy Processing Systems Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Automated & Closed Cell Therapy Processing Systems Market
17. China Automated & Closed Cell Therapy Processing Systems Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Bio-Techne Corporation
18.6. BioLife Solutions Inc.
18.7. BioSpherix, Ltd.
18.8. Cellares Inc.
18.9. Corning Incorporated
18.10. Cytiva
18.11. Danaher Corporation
18.12. Fresenius SE & Co. KGaA
18.13. General Electric Company
18.14. Lonza Group AG
18.15. Merck KGaA
18.16. Miltenyi Biotec B.V. & Co. KG
18.17. Novartis AG
18.18. Pluristem Therapeutics Inc.
18.19. Regeneus Ltd.
18.20. Sartorius AG
18.21. STEMCELL Technologies Canada Inc.
18.22. Terumo Corporation
18.23. Thermo Fisher Scientific, Inc.
18.24. Thermogenesis Holdings, Inc.
List of Figures
FIGURE 1. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PROCESS TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY AUTOMATED SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY AUTOMATED SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY AUTOMATED SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CLOSED SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CLOSED SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CLOSED SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CENTRIFUGATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CENTRIFUGATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CENTRIFUGATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CENTRIFUGATION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY DENSITY GRADIENT CENTRIFUGATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY DENSITY GRADIENT CENTRIFUGATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY DENSITY GRADIENT CENTRIFUGATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY FIXED ANGLE CENTRIFUGATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY FIXED ANGLE CENTRIFUGATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY FIXED ANGLE CENTRIFUGATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SWING BUCKET CENTRIFUGATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SWING BUCKET CENTRIFUGATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SWING BUCKET CENTRIFUGATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY FILTRATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY FILTRATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY FILTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY FILTRATION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MICROFILTRATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MICROFILTRATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MICROFILTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY ULTRAFILTRATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY ULTRAFILTRATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY ULTRAFILTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MAGNETIC SEPARATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MAGNETIC SEPARATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MAGNETIC SEPARATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MAGNETIC SEPARATION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY IMMUNOMAGNETIC BEAD SEPARATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY IMMUNOMAGNETIC BEAD SEPARATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY IMMUNOMAGNETIC BEAD SEPARATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PARAMAGNETIC SEPARATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PARAMAGNETIC SEPARATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PARAMAGNETIC SEPARATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL COUNTING & ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL COUNTING & ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL COUNTING & ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL COUNTING & ANALYSIS, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY AUTOMATED COUNTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY AUTOMATED COUNTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY AUTOMATED COUNTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MANUAL COUNTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MANUAL COUNTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MANUAL COUNTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL SEPARATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL SEPARATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL SEPARATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL SEPARATION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CENTRIFUGATION SEPARATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CENTRIFUGATION SEPARATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CENTRIFUGATION SEPARATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY FILTRATION SEPARATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY FILTRATION SEPARATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY FILTRATION SEPARATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MAGNETIC SEPARATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MAGNETIC SEPARATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MAGNETIC SEPARATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL PREPARATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL PREPARATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL PREPARATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL STORAGE, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL STORAGE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL WASHING, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL WASHING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL WASHING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY ALLOGENEIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY ALLOGENEIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY ALLOGENEIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY ALLOGENEIC, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY HEMATOPOIETIC STEM CELL THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY HEMATOPOIETIC STEM CELL THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY HEMATOPOIETIC STEM CELL THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY NATURAL KILLER CELL THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY NATURAL KILLER CELL THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY NATURAL KILLER CELL THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY AUTOLOGOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY AUTOLOGOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY AUTOLOGOUS, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CAR T CELL THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CAR T CELL THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CAR T CELL THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MESENCHYMAL STEM CELL THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MESENCHYMAL STEM CELL THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MESENCHYMAL STEM CELL THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 111. AMERICAS AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 112. AMERICAS AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 113. AMERICAS AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 114. AMERICAS AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CENTRIFUGATION, 2018-2032 (USD MILLION)
TABLE 115. AMERICAS AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY FILTRATION, 2018-2032 (USD MILLION)
TABLE 116. AMERICAS AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MAGNETIC SEPARATION, 2018-2032 (USD MILLION)
TABLE 117. AMERICAS AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
TABLE 118. AMERICAS AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL COUNTING & ANALYSIS, 2018-2032 (USD MILLION)
TABLE 119. AMERICAS AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL SEPARATION, 2018-2032 (USD MILLION)
TABLE 120. AMERICAS AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 121. AMERICAS AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY ALLOGENEIC, 2018-2032 (USD MILLION)
TABLE 122. AMERICAS AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY AUTOLOGOUS, 2018-2032 (USD MILLION)
TABLE 123. AMERICAS AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 124. NORTH AMERICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 125. NORTH AMERICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 126. NORTH AMERICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 127. NORTH AMERICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CENTRIFUGATION, 2018-2032 (USD MILLION)
TABLE 128. NORTH AMERICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY FILTRATION, 2018-2032 (USD MILLION)
TABLE 129. NORTH AMERICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MAGNETIC SEPARATION, 2018-2032 (USD MILLION)
TABLE 130. NORTH AMERICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
TABLE 131. NORTH AMERICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL COUNTING & ANALYSIS, 2018-2032 (USD MILLION)
TABLE 132. NORTH AMERICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL SEPARATION, 2018-2032 (USD MILLION)
TABLE 133. NORTH AMERICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 134. NORTH AMERICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY ALLOGENEIC, 2018-2032 (USD MILLION)
TABLE 135. NORTH AMERICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY AUTOLOGOUS, 2018-2032 (USD MILLION)
TABLE 136. NORTH AMERICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 137. LATIN AMERICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 138. LATIN AMERICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 139. LATIN AMERICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 140. LATIN AMERICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CENTRIFUGATION, 2018-2032 (USD MILLION)
TABLE 141. LATIN AMERICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY FILTRATION, 2018-2032 (USD MILLION)
TABLE 142. LATIN AMERICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MAGNETIC SEPARATION, 2018-2032 (USD MILLION)
TABLE 143. LATIN AMERICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
TABLE 144. LATIN AMERICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL COUNTING & ANALYSIS, 2018-2032 (USD MILLION)
TABLE 145. LATIN AMERICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL SEPARATION, 2018-2032 (USD MILLION)
TABLE 146. LATIN AMERICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 147. LATIN AMERICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY ALLOGENEIC, 2018-2032 (USD MILLION)
TABLE 148. LATIN AMERICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY AUTOLOGOUS, 2018-2032 (USD MILLION)
TABLE 149. LATIN AMERICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CENTRIFUGATION, 2018-2032 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY FILTRATION, 2018-2032 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MAGNETIC SEPARATION, 2018-2032 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL COUNTING & ANALYSIS, 2018-2032 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL SEPARATION, 2018-2032 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY ALLOGENEIC, 2018-2032 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY AUTOLOGOUS, 2018-2032 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 163. EUROPE AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 164. EUROPE AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 165. EUROPE AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 166. EUROPE AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CENTRIFUGATION, 2018-2032 (USD MILLION)
TABLE 167. EUROPE AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY FILTRATION, 2018-2032 (USD MILLION)
TABLE 168. EUROPE AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MAGNETIC SEPARATION, 2018-2032 (USD MILLION)
TABLE 169. EUROPE AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
TABLE 170. EUROPE AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL COUNTING & ANALYSIS, 2018-2032 (USD MILLION)
TABLE 171. EUROPE AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL SEPARATION, 2018-2032 (USD MILLION)
TABLE 172. EUROPE AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 173. EUROPE AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY ALLOGENEIC, 2018-2032 (USD MILLION)
TABLE 174. EUROPE AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY AUTOLOGOUS, 2018-2032 (USD MILLION)
TABLE 175. EUROPE AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 176. MIDDLE EAST AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 177. MIDDLE EAST AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 178. MIDDLE EAST AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 179. MIDDLE EAST AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CENTRIFUGATION, 2018-2032 (USD MILLION)
TABLE 180. MIDDLE EAST AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY FILTRATION, 2018-2032 (USD MILLION)
TABLE 181. MIDDLE EAST AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MAGNETIC SEPARATION, 2018-2032 (USD MILLION)
TABLE 182. MIDDLE EAST AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
TABLE 183. MIDDLE EAST AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL COUNTING & ANALYSIS, 2018-2032 (USD MILLION)
TABLE 184. MIDDLE EAST AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL SEPARATION, 2018-2032 (USD MILLION)
TABLE 185. MIDDLE EAST AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 186. MIDDLE EAST AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY ALLOGENEIC, 2018-2032 (USD MILLION)
TABLE 187. MIDDLE EAST AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY AUTOLOGOUS, 2018-2032 (USD MILLION)
TABLE 188. MIDDLE EAST AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 189. AFRICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. AFRICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 191. AFRICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 192. AFRICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CENTRIFUGATION, 2018-2032 (USD MILLION)
TABLE 193. AFRICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY FILTRATION, 2018-2032 (USD MILLION)
TABLE 194. AFRICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MAGNETIC SEPARATION, 2018-2032 (USD MILLION)
TABLE 195. AFRICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
TABLE 196. AFRICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL COUNTING & ANALYSIS, 2018-2032 (USD MILLION)
TABLE 197. AFRICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL SEPARATION, 2018-2032 (USD MILLION)
TABLE 198. AFRICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 199. AFRICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY ALLOGENEIC, 2018-2032 (USD MILLION)
TABLE 200. AFRICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY AUTOLOGOUS, 2018-2032 (USD MILLION)
TABLE 201. AFRICA AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 202. ASIA-PACIFIC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 203. ASIA-PACIFIC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 204. ASIA-PACIFIC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 205. ASIA-PACIFIC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CENTRIFUGATION, 2018-2032 (USD MILLION)
TABLE 206. ASIA-PACIFIC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY FILTRATION, 2018-2032 (USD MILLION)
TABLE 207. ASIA-PACIFIC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MAGNETIC SEPARATION, 2018-2032 (USD MILLION)
TABLE 208. ASIA-PACIFIC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
TABLE 209. ASIA-PACIFIC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL COUNTING & ANALYSIS, 2018-2032 (USD MILLION)
TABLE 210. ASIA-PACIFIC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL SEPARATION, 2018-2032 (USD MILLION)
TABLE 211. ASIA-PACIFIC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 212. ASIA-PACIFIC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY ALLOGENEIC, 2018-2032 (USD MILLION)
TABLE 213. ASIA-PACIFIC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY AUTOLOGOUS, 2018-2032 (USD MILLION)
TABLE 214. ASIA-PACIFIC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 215. GLOBAL AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 216. ASEAN AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 217. ASEAN AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 218. ASEAN AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 219. ASEAN AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CENTRIFUGATION, 2018-2032 (USD MILLION)
TABLE 220. ASEAN AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY FILTRATION, 2018-2032 (USD MILLION)
TABLE 221. ASEAN AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MAGNETIC SEPARATION, 2018-2032 (USD MILLION)
TABLE 222. ASEAN AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
TABLE 223. ASEAN AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL COUNTING & ANALYSIS, 2018-2032 (USD MILLION)
TABLE 224. ASEAN AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL SEPARATION, 2018-2032 (USD MILLION)
TABLE 225. ASEAN AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 226. ASEAN AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY ALLOGENEIC, 2018-2032 (USD MILLION)
TABLE 227. ASEAN AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY AUTOLOGOUS, 2018-2032 (USD MILLION)
TABLE 228. ASEAN AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 229. GCC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 230. GCC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 231. GCC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 232. GCC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CENTRIFUGATION, 2018-2032 (USD MILLION)
TABLE 233. GCC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY FILTRATION, 2018-2032 (USD MILLION)
TABLE 234. GCC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MAGNETIC SEPARATION, 2018-2032 (USD MILLION)
TABLE 235. GCC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
TABLE 236. GCC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL COUNTING & ANALYSIS, 2018-2032 (USD MILLION)
TABLE 237. GCC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL SEPARATION, 2018-2032 (USD MILLION)
TABLE 238. GCC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 239. GCC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY ALLOGENEIC, 2018-2032 (USD MILLION)
TABLE 240. GCC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY AUTOLOGOUS, 2018-2032 (USD MILLION)
TABLE 241. GCC AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 242. EUROPEAN UNION AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 243. EUROPEAN UNION AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 244. EUROPEAN UNION AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 245. EUROPEAN UNION AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CENTRIFUGATION, 2018-2032 (USD MILLION)
TABLE 246. EUROPEAN UNION AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY FILTRATION, 2018-2032 (USD MILLION)
TABLE 247. EUROPEAN UNION AUTOMATED & CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MAGNETIC SEPARATI

Companies Mentioned

The key companies profiled in this Automated & Closed Cell Therapy Processing Systems market report include:
  • Bio-Techne Corporation
  • BioLife Solutions Inc.
  • BioSpherix, Ltd.
  • Cellares Inc.
  • Corning Incorporated
  • Cytiva
  • Danaher Corporation
  • Fresenius SE & Co. KGaA
  • General Electric Company
  • Lonza Group AG
  • Merck KGaA
  • Miltenyi Biotec B.V. & Co. KG
  • Novartis AG
  • Pluristem Therapeutics Inc.
  • Regeneus Ltd.
  • Sartorius AG
  • STEMCELL Technologies Canada Inc.
  • Terumo Corporation
  • Thermo Fisher Scientific, Inc.
  • Thermogenesis Holdings, Inc.

Table Information

Report AttributeDetails
No. of Pages182
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.43 Billion
Forecasted Market Value ( USD ) by 2032 $ 3.63 Billion
Compound Annual Growth Rate16.4%
Regions CoveredGlobal
No. of Companies Mentioned20

Related Topics

Related Reports

Cell Therapy Biomanufacturing Market - Global Forecast 2026-2032 - Product Image

Cell Therapy Biomanufacturing Market - Global Forecast 2026-2032

  • Report
  • 181 Pages
  • Global
From
Cell Processing Systems for Cell Therapy Market - Global Forecast 2025-2030 - Product Image

Cell Processing Systems for Cell Therapy Market - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
Automated and Closed Cell Therapy Processing Systems - Global Strategic Business Report - Product Image

Automated and Closed Cell Therapy Processing Systems - Global Strategic Business Report

  • Report
  • 138 Pages
  • Global
From
Cell Therapy Processing Market Report 2025 - Product Image

Cell Therapy Processing Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Automated and Closed Cell Therapy Processing Systems Market Report 2025 - Product Image

Automated and Closed Cell Therapy Processing Systems Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.